Adhesion Properties and Pathogen Inhibition of Vaginal-Derived Lactobacilli
- PMID: 39565565
- DOI: 10.1007/s12602-024-10390-5
Adhesion Properties and Pathogen Inhibition of Vaginal-Derived Lactobacilli
Abstract
In the present study, twenty-seven (27) lactobacilli strains, isolated from the vagina of healthy Italian women of reproductive age, were screened for probiotic properties. The strains were evaluated for antagonistic activity against pathogens, adhesion abilities, and potential to displace and/or inhibit the adhesion of previously adhered pathogens as a primary strain selection criterion. Overall, all the tested lactobacilli inhibited at least three pathogens, and the majority of them exhibited antimicrobial activity against Enterobacter cloacae DSM 30054, Pseudomonas aeruginosa DSM 3227, and Pseudomonas aeruginosa DSM 1117. The complete neutralization of antimicrobial activity after cell-free supernatant (CFS) neutralization suggested a pivotal role for lactic acid or other organic acids secreted by the lactobacilli. The strains showed variability in their adhesion levels, but all tested strains adhered to both human colonic epithelial cells (HT-29) and vaginal cells (VK2/E6E7) with adhesion percentages exceeding 1%. The ability to displace or inhibit pathogens was dependent on the pathogen and the lactobacilli strain; the pathogen displacement levels ranged from 9 to 82%, while pathogen exclusion levels varied from 1 to 99%. In conclusion, this study demonstrates the protective effect of vaginal lactobacilli against pathogens and confirms the suitability of the vaginal microbiota as a source of potential probiotic strains. The selected lactobacilli hold promise for the formulation of supplements to enhance genitourinary tract health.
Keywords: Antimicrobial activity; Human colonic epithelial cells; Intestinal mucus; Probiotic; Vaginal cells.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: The authors declare no competing interests.
Similar articles
-
Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells.Lett Appl Microbiol. 2006 Aug;43(2):174-80. doi: 10.1111/j.1472-765X.2006.01934.x. Lett Appl Microbiol. 2006. PMID: 16869901
-
Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus.Lett Appl Microbiol. 2007 Oct;45(4):454-60. doi: 10.1111/j.1472-765X.2007.02212.x. Lett Appl Microbiol. 2007. PMID: 17897389
-
In vitro evaluation on HeLa cells of protective mechanisms of probiotic lactobacilli against Candida clinical isolates.J Appl Microbiol. 2015 Nov;119(5):1383-90. doi: 10.1111/jam.12947. Epub 2015 Oct 5. J Appl Microbiol. 2015. PMID: 26335148
-
[Criteria for selection of lactobacilli for probiotic use].Vet Med (Praha). 1997 Jan;42(1):19-27. Vet Med (Praha). 1997. PMID: 9123779 Review. Slovak.
-
Vaginal microbiome.Ceska Gynekol. 2018 Winter;83(5):371-379. Ceska Gynekol. 2018. PMID: 30848142 Review. English.
References
-
- Kelly VW, Liang BK, Sirk SJ (2020) Living therapeutics: the next frontier of precision medicine. ACS Synth Biol 9(12):3184–3201. https://doi.org/10.1021/acssynbio.0c00444 - DOI - PubMed
-
- Zheng J, Wittouck S, Salvetti E, Franz CMAP, Harris HMB, Mattarelli P, O’Toole PW, Pot B, Vandamme P, Walter J, Watanabe K, Wuyts S, Felis GE, Gänzle MG, Lebeer S (2020) A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol 70(4):2782–2858. https://doi.org/10.1099/ijsem.0.004107 - DOI - PubMed
-
- Homayouni Rad A, Pourjafar H, Mirzakhani E (2023) A comprehensive review of the application of probiotics and postbiotics in oral health. Front Cell Infect Microbiol 13:1120995. https://doi.org/10.3389/fcimb.2023.1120995 - DOI - PubMed - PMC
-
- Liu P, Lu Y, Li R, Chen X (2023) Use of probiotic lactobacilli in the treatment of vaginal infections: in vitro and in vivo investigations. Front Cell Infect Microbiol 13:1153894. https://doi.org/10.3389/fcimb.2023.1153894 - DOI - PubMed - PMC
-
- Cunningham M, Azcarate-Peril MA, Barnard A, Benoit V, Grimaldi R, Guyonnet D, Holscher HD, Hunter K, Manurung S, Obis D, Petrova MI, Steinert RE, Swanson KS, van Sinderen D, Vulevic J, Gibson GR (2021) Shaping the future of probiotics and prebiotics. Trends Microbiol 29(8):667–685. https://doi.org/10.1016/j.tim.2021.01.003 - DOI - PubMed